Product Information

Omapatrilat is a dipeptide.

CAS No.	167305-00-2
Product Name	Omapatrilat

Heavy Atom Count	27	Rotatable Bond Count	5
Atom Stereo Count	4	Bond Stereo Count	0
HBA	5	HBD	3
TPSA	86.710 Å²	Charge	0
Exact Mass	408.11775	Complexity	700.21
pKa	4.405	XLogP	1.941

Studies related to this compound and its mechanism of action

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.

British journal of pharmacology • Vol. 153, Issue 5 • 2008

PMID: 18084312 PMC: PMC2267285 DOI: 10.1038/sj.bjp.0707641

Omapatrilat enhances adrenomedullin's reduction of cardiomyocyte cell death.

European journal of pharmacology • Vol. 562, Issue 3 • 2007

PMID: 17343842 DOI: 10.1016/j.ejphar.2007.01.056

Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats.

European journal of pharmacology • Vol. 519, Issue 3 • 2005

PMID: 16137672 DOI: 10.1016/j.ejphar.2005.07.015

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.

American journal of hypertension • Vol. 17, Issue 2 • 2004

PMID: 14751650 DOI: 10.1016/j.amjhyper.2003.09.014

Omapatrilat

CAS No.	167305-00-2
MDL No.	N/A
MF	C₁₉H₂₄N₂O₄S₂
MW	408.50
InChI Key	LVRLSYPNFFBYCZ-VGWMRTNUSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Omapatrilat is a dipeptide.

CAS No.	167305-00-2
Product Name	Omapatrilat

Heavy Atom Count	27	Rotatable Bond Count	5
Atom Stereo Count	4	Bond Stereo Count	0
HBA	5	HBD	3
TPSA	86.710 Å²	Charge	0
Exact Mass	408.11775	Complexity	700.21
pKa	4.405	XLogP	1.941

Omapatrilat

Pricing & Availability

Product Information

Properties

Omapatrilat

Pricing & Availability

Product Information

Properties

Documentation

Omapatrilat

Pricing & Availability

Product Information

Properties

Related Articles

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.

Omapatrilat enhances adrenomedullin's reduction of cardiomyocyte cell death.

Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats.

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.

Omapatrilat

Pricing & Availability

Product Information

Properties

Related Articles

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.

Omapatrilat enhances adrenomedullin's reduction of cardiomyocyte cell death.

Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats.

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.

Documentation